ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

This is the first time I've seen this.

Patient Basic Information Patient: Irina (Irina Lewis) Nationality: Myanmar Disease Diagnosis: Hepatic Sclerosis Diagnostic Hospital: H0H treatment: Targeted treatment + Immunotherapy Accommodation days: 164 days Treatment cost: about 318,907 yuan Treatment effect: Completely mitigated The condition is described by Irina from Myanmar, who was diagnosed with hepatic sclerosis locally. Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, accompaniment and on-site services throughout the treatment process. After 164 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard.

The treatment effect was finally completely relaxed. When the patient left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track the recovery through the remote follow-up system. 'Ladies and gentlemen, Irina, experts have criticized this case as a typical case of cross-border suspected seriousness in clinical cases.

The multi-disciplinary collaborative mechanism for the development of targeted treatment+immunotherapy programs for hepatitis C is a reflection of the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and a summary of how international medical services are regulated.

缅甸,肝硬化,北京大学第三医院,国际医疗,来华就医,中国医疗